Trazodone Use in 15-Year-Olds for Sleep
Trazodone is NOT recommended for sleep in a 15-year-old adolescent. The safety and effectiveness of trazodone in patients under 18 years has not been established, and current guidelines specifically recommend against its use for insomnia treatment even in adults 1, 2.
Why Trazodone Should Be Avoided
Lack of FDA Approval and Safety Data
- Trazodone is not FDA-approved for insomnia at any age—it is only approved for major depressive disorder in adults 3
- The FDA drug label explicitly states: "Safety/effectiveness in patients <18 years not established" 1
- The 2017 American Academy of Sleep Medicine guideline specifically recommends against using trazodone for sleep onset or maintenance insomnia in adults, based on insufficient evidence of efficacy 2
Concerning Evidence in Adolescents
Research specific to adolescents raises serious red flags:
- In treatment-resistant depression studies, adolescents receiving trazodone were 6 times less likely to respond to treatment and 3 times more likely to experience self-harm 4
- When combined with certain SSRIs (fluoxetine or paroxetine), 0% of adolescents responded (0/13 patients) 4
- While one older study showed trazodone resolved insomnia slightly faster than fluoxetine in depressed adolescents (2.5 vs 5.1 days), this difference was deemed "not clinically significant" 5
Significant Side Effect Profile
Trazodone carries substantial risks that are particularly concerning in adolescents:
- Suicidal thoughts/actions: Black box warning for increased risk in children, teenagers, and young adults 3
- Priapism: Painful erections >6 hours requiring emergency treatment 3
- Orthostatic hypotension and syncope (fainting) 3
- Serotonin syndrome when combined with other serotonergic medications 3
- Common side effects: dizziness, drowsiness, sedation, headache, nausea 3
Recommended Alternatives for Adolescent Insomnia
First-Line Approach: Non-Pharmacological Treatment
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the initial treatment 1. This includes:
- Stimulus control therapy: Associating bed with sleep only
- Sleep restriction therapy: Limiting time in bed to actual sleep time
- Sleep hygiene education: Regular schedule, quiet environment, avoiding caffeine/screens before bed
- Relaxation techniques: Progressive muscle relaxation, breathing exercises
Pharmacological Options When Necessary
If medication is clinically necessary after behavioral interventions fail:
Most Appropriate First Choice: Melatonin
- A 2022 guideline on pediatric sleep disorders identified melatonin as the most popular first-choice treatment among pediatric psychiatrists (57% of respondents) 6
- Consider extended-release melatonin for sleep maintenance issues 6
- Dosing typically starts at 1-3 mg, taken 30-60 minutes before bedtime
- Important caveat: The 2017 adult insomnia guideline recommends against melatonin for chronic insomnia in adults 2, but pediatric practice patterns differ, and melatonin has a superior safety profile in adolescents
Second-Line Considerations (with specialist consultation):
If melatonin is ineffective and a specialist sleep medicine evaluation has ruled out underlying sleep disorders:
Low-dose mirtazapine (7.5-15 mg)
- Listed as second choice after melatonin in pediatric practice 6
- Has sedating properties at low doses
- Monitor for weight gain and increased appetite
- More evidence in adults than adolescents
Alpha-2 agonists (clonidine, guanfacine)
- Sometimes used off-label for sleep in children with ADHD or autism
- Requires cardiovascular monitoring
Medications to AVOID in adolescents:
- Benzodiazepines: Risk of dependency, respiratory depression, cognitive impairment 1, 7
- Antihistamines (diphenhydramine, hydroxyzine): Tolerance develops after 3-4 days; anticholinergic effects problematic 7
- Antipsychotics (quetiapine, olanzapine): Serious metabolic side effects; not appropriate for insomnia alone 1, 7
- Over-the-counter "sleep aids": Lack efficacy data, especially for long-term use 1
Critical Action Steps
Evaluate for underlying causes before prescribing any medication:
- Depression, anxiety, or other psychiatric conditions
- Sleep-disordered breathing (sleep apnea)
- Restless leg syndrome or periodic limb movements
- Medication side effects (stimulants, corticosteroids)
- Substance use (caffeine, energy drinks, cannabis)
- Screen time and sleep hygiene issues
Refer to sleep medicine specialist if:
- Symptoms suggest sleep apnea (snoring, witnessed apneas, daytime sleepiness)
- Insomnia persists despite behavioral interventions
- Considering prescription sleep medications
If depression is present, treat the depression appropriately with an SSRI at therapeutic doses—do not use low-dose trazodone as it provides inadequate antidepressant treatment 1
Common Pitfall to Avoid
Do not prescribe trazodone simply because "it's commonly used" or "it's not a controlled substance." Despite widespread off-label use in clinical practice, the evidence does not support its efficacy for insomnia, particularly in adolescents, and the risk-benefit ratio is unfavorable 2, 4. The fact that 57% of pediatric psychiatrists listed trazodone as their second choice (after melatonin) 6 reflects practice patterns, not evidence-based recommendations.